Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126570551 | 12657055 | 1 | I | 2015 | 20160808 | 20160816 | 20160816 | EXP | US-DSJP-DSU-2016-126922 | DAIICHI | 0.00 | Y | 0.00000 | 20160816 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126570551 | 12657055 | 1 | PS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40/25 MG, QD | 21532 | 1 | DF | FILM-COATED TABLET | QD | ||||||
126570551 | 12657055 | 2 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | TABLET | QD | ||||||
126570551 | 12657055 | 3 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | UNK, 3 TIMES PER 1WK | 0 | TIW | |||||||||
126570551 | 12657055 | 4 | C | FISH OIL | FISH OIL | 1 | Oral | UNK | 0 | ||||||||||
126570551 | 12657055 | 5 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Oral | 5000 UNITS, QD | 0 | QD | |||||||||
126570551 | 12657055 | 6 | C | COENZYME | UBIDECARENONE | 1 | 100 MG, QD | 0 | 100 | MG | QD | ||||||||
126570551 | 12657055 | 7 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | 100 UNK, QD | 0 | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126570551 | 12657055 | 1 | Hypertension |
126570551 | 12657055 | 2 | Hypertension |
126570551 | 12657055 | 3 | Blood cholesterol increased |
126570551 | 12657055 | 4 | Supplementation therapy |
126570551 | 12657055 | 5 | Supplementation therapy |
126570551 | 12657055 | 6 | Supplementation therapy |
126570551 | 12657055 | 7 | Supplementation therapy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126570551 | 12657055 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126570551 | 12657055 | Hypoaesthesia | |
126570551 | 12657055 | Muscle rupture | |
126570551 | 12657055 | Muscle spasms | |
126570551 | 12657055 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126570551 | 12657055 | 1 | 2015 | 0 | ||
126570551 | 12657055 | 2 | 2015 | 0 |